Northern Trust Corp Sigilon Therapeutics, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.74 - $1.64 $68,938 - $152,782	-93,160 Reduced 79.45%	24,089 $20,000
Q1 2022 May 13, 2022	SELL	$1.24 - $3.03 $7,117 - $17,392	-5,740 Reduced 4.67%	117,249 $172,000
Q4 2021 Feb 08, 2022	BUY	$2.58 - $6.13 $4,672 - $11,101	1,811 Added 1.49%	122,989 $339,000
Q3 2021 Nov 15, 2021	BUY	$4.42 - $10.61 $207,187 - $497,343	46,875 Added 63.09%	121,178 $685,000
Q2 2021 Aug 13, 2021	SELL	$9.15 - $20.17 $92,332 - $203,535	-10,091 Reduced 11.96%	74,303 $797,000
Q1 2021 May 12, 2021	BUY	$18.76 - $40.91 $1.58 Million - $3.45 Million	84,394 New	84,394 $1.89 Million

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.